These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32361603)

  • 41. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
    Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
    Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of
    Yaltirik CK; Yilmaz SG; Ozdogan S; Bilgin EY; Barut Z; Ture U; Isbir T
    In Vivo; 2022; 36(4):1694-1702. PubMed ID: 35738587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.
    Jiang R; Jiang J; Zhao L; Zhang J; Zhang S; Yao Y; Yang S; Shi J; Shen N; Su C; Zhang J; Zhu W
    Oncotarget; 2015 Dec; 6(39):42380-93. PubMed ID: 26544514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of diffuse glioma grade and proliferation activity by different diffusion-weighted-imaging models including diffusion kurtosis imaging (DKI) and mean apparent propagator (MAP) MRI.
    Xie SH; Lang R; Li B; Zhao H; Wang P; He JL; Ma XY; Wu Q; Wang SY; Zhang HP; Gao Y; Wu JL
    Neuroradiology; 2023 Jan; 65(1):55-64. PubMed ID: 35835879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of gliomas peritumoral diffusion and prediction of IDH1 mutation by IVIM-DWI.
    Gu T; Yang T; Huang J; Yu J; Ying H; Xiao X
    Aging (Albany NY); 2021 Mar; 13(7):9948-9959. PubMed ID: 33795525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain.
    Lanzafame S; Giannelli M; Garaci F; Floris R; Duggento A; Guerrisi M; Toschi N
    Med Phys; 2016 May; 43(5):2464. PubMed ID: 27147357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.
    Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y
    Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
    J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
    Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
    Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
    Wu XF; Liang X; Wang XC; Qin JB; Zhang L; Tan Y; Zhang H
    Eur J Radiol; 2021 Feb; 135():109445. PubMed ID: 33341429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Diffusional Kurtosis Imaging in Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis: Comparison With Diffusion-Weighted Imaging.
    Lu P; Yuan T; Liu X; Tian G; Zhang J; Sha Y
    J Comput Assist Tomogr; 2020; 44(1):47-52. PubMed ID: 31939881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models.
    Mao J; Zeng W; Zhang Q; Yang Z; Yan X; Zhang H; Wang M; Yang G; Zhou M; Shen J
    BMC Med Imaging; 2020 Nov; 20(1):124. PubMed ID: 33228564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation of high-grade-astrocytomas from solitary-brain-metastases: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
    Tan Y; Wang XC; Zhang H; Wang J; Qin JB; Wu XF; Zhang L; Wang L
    Eur J Radiol; 2015 Dec; 84(12):2618-24. PubMed ID: 26482747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Multiregional Mean Apparent Propagator (MAP) Features in Evaluating Gliomas-A Comparative Study With Diffusion Kurtosis Imaging (DKI).
    Zeng S; Ma H; Xie D; Huang Y; Yang J; Lin F; Ma Z; Wang M; Yang Z; Zhao J; Chu J
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38131220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.
    Schäfer S; Behling F; Skardelly M; Koch M; Ott I; Paulsen F; Tabatabai G; Schittenhelm J
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):207-223. PubMed ID: 29053887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
    Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
    Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.